<DOC>
	<DOCNO>NCT00505427</DOCNO>
	<brief_summary>The study recruit 40 subject Polycystic Ovary Syndrome ( PCOS ) define NIH criterion . The subject pre-screened insulin sensitivity use fast insulin glucose level oral glucose tolerance test . The 20 insulin resistant subject undergo measurement vivo insulin action hyperinsulinemic , euglycemic clamp . Body composition measure dual-energy X-ray absorptiometry ( DEXA ) . Plasma lipids marker oxidative stress measure . They receive open label control release alpha lipoic acid ( CRLA ) 800 mg twice daily 16 week . After treatment hyperinsulinemic euglycemic clamp , DEXA , plasma lipid marker oxidative stress repeat . Hypotheses : LA improve insulin sensitivity PCOS subject ; LA reduce oxidative stress , testosterone level improve cardiovascular risk factor .</brief_summary>
	<brief_title>Alpha Lipoic Acid Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Insulin resistance commonly occur patient Polycystic Ovary Syndrome ( PCOS ) may responsible many long term complication PCOS . Patients PCOS increase risk develop type 2 diabetes metabolic syndrome ( hypertension , dyslipidemia cardiovascular disease ) . Data suggest oxidative stress contributes insulin resistance thus inhibitor oxidative stress improve insulin action . Alpha Lipoic Acid ( LA ) synthesize liver tissue key component several mitochondrial enzyme complex responsible oxidative glucose metabolism cellular energy production . When use pharmacologically , LA function safe effective antioxidant , recycle vitamin C E , elevate glutathione level , lower reactive oxygen specie . Cell culture study reveal LA reverse effect oxidative stress improve insulin action . Preliminary clinical data indicate antioxidant may improve insulin resistance PCOS patient . We propose , therefore , study LA 's effect insulin-stimulated glucose uptake ( insulin clamp ) well characterize population insulin resistant PCOS patient . Because patient usually present adolescent teenage year , development safe , long-term , treatment strategy need .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>PCOS diagnosis 18 year age old Body Mass Index 35 Willing use form contraception duration study Diabetes Pregnancy Liver heart disease health problem Taking medication affect insulin resistance</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>PCOS</keyword>
	<keyword>polycystic ovary syndrome</keyword>
	<keyword>polycystic ovarian syndrome</keyword>
	<keyword>alpha lipoic acid</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>oxidative stress</keyword>
</DOC>